<DOC>
	<DOCNO>NCT00354796</DOCNO>
	<brief_summary>We hypothesize reduce dose enoxaparin elderly patient result reduce proportion patient therapeutic anti Xa activity reduce clinical efficacy .</brief_summary>
	<brief_title>The Effect Reduced Dose Enoxaparin Outcomes Treatment With Enoxaparin</brief_title>
	<detailed_description>Patients treat enoxaparin follow , sociodemographic , clinical laboratory data collect . Clinical efficacy well adverse event monitor .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Thrombophilia</mesh_term>
	<criteria>treatment enoxaparin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>bleeding</keyword>
	<keyword>anticoagulation</keyword>
	<keyword>LMWH</keyword>
	<keyword>Enoxaparin</keyword>
</DOC>